Harman Finochem Ltd Revenue and Competitors

Mumbai, India

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Harman Finochem Ltd's estimated annual revenue is currently $3.5M per year.(i)
  • Harman Finochem Ltd's estimated revenue per employee is $4,575

Employee Data

  • Harman Finochem Ltd has 765 Employees.(i)
  • Harman Finochem Ltd grew their employee count by 19% last year.

Harman Finochem Limited is a professionally managed independent company engaged in manufacturing of Active Pharmaceutical ingredients (API's) and chemical intermediates. The company was established way back in 1983 by Bhupinder Singh Manhas, the CMD of the company. • Manufacturer and Exporter of Active Pharmaceutical Ingredients. • Two manufacturing sites at Aurangabad and one at Vapi with capacity of 350,000 Litres. • Supply of API"s as a Major Thrust Area to Pharma and Generic companies. • Certificate of recognition as 'EXPORT HOUSE' by Government of India. • State of the art manufacturing facilities inspected and complying with cGMP norms as per USFDA, ICH Q7A, TGA, PIC, WHO – GMP, Schedule M and Japanese Foreign Accreditation. • State-of-the-art Quality Control Laboratories with GLP compliance. • cGMP compliance Pilot plant with clean room facility. • Powder processing area with pneumatic controls and Particle Size options: Milling & Micronising. • CRAMs offered.

keywords:N/A

N/A

Total Funding

765

Number of Employees

$3.5M

Revenue (est)

19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Harman Finochem Ltd News

2022-04-20 - Mercado global Divalproex Sodium API 2022 Empresas clave ...

... Divalproex Sodium API 2022 Empresas clave | Dr. Reddy's Laboratories Ltd., SCI PHARMTECH, Anjan Drug Private Limited, Harman Finochem...

2022-04-17 - Global Cyclobenzaprine Market Geographical Growth ...

API Polpharma · Admiron · Jubilant Pharma · Cemex Pharma · Harman Finochem Limited · RA Chem Pharma Ltd · Guilin Hwasun Pharmacentical · LGM Pharma.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$69.6M76521%$241M
#2
$76.8M7670%$20.5M
#3
$108.6M76818%N/A
#4
$78.1M76925%N/A
#5
$3.5M7713%N/A